Adam Riess

Camden Partners closes biomedical technology-focused venture capital fund

Camden Partners closes biomedical technology-focused venture capital fund

Camden Partners Holdings, a Baltimore-based private equity firm co-founded by former mayoral candidate David L. Warnock, announced the final closing of its Nexus fund, which invests in early-stage biomedical technology companies.

The Camden Partners Nexus Fund aims to invest in firms, particularly in Baltimore, that develop drugs, devices, diagnostics and data analytics through federally funded research and development grants, including those with technologies emerging from the divisions at the Johns Hopkins University and the University of Maryland.

Warnock launched the fund in 2016, along with Dr. R. Jacob Vogelstein, George C. Petrocheilos and Davis Oros. It has made six...

72°